Lineage Cell Therapeutics In shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $48k | 28k | 1.69 |
| 2025-06-30 | $25k | 28k | 0.91 |
| 2025-03-31 | $51k | 113k | 0.45 |
| 2024-12-31 | $48k | 95k | 0.50 |
| 2024-09-30 | $65k | 71k | 0.91 |
| 2024-06-30 | $67k | 67k | 1.00 |
| 2024-03-31 | $89k | 60k | 1.48 |
| 2023-12-31 | $66k | 61k | 1.09 |
| 2023-09-30 | $62k | 52k | 1.18 |
| 2023-06-30 | $113k | 80k | 1.41 |
| 2022-12-31 | $31k | 27k | 1.14 |
| 2022-09-30 | $6.5k | 5.5k | 1.18 |
| 2022-06-30 | $10k | 8.5k | 1.19 |
| 2022-03-31 | $312k | 203k | 1.54 |
| 2021-12-31 | $1.3M | 525k | 2.45 |
| 2021-09-30 | $0 | 704k | 0.00 |
| 2021-06-30 | $30k | 11k | 2.89 |
| 2021-03-31 | $22k | 9.6k | 2.31 |
| 2020-12-31 | $232k | 131k | 1.77 |
| 2020-09-30 | $121k | 129k | 0.94 |
| 2020-06-30 | $135k | 155k | 0.87 |
| 2020-03-31 | $250k | 300k | 0.83 |
| 2019-12-31 | $162k | 182k | 0.89 |
| 2019-09-30 | $50k | 51k | 0.98 |